China NMPA Drug Inspection - Guangxi Bangqi Pharmaceutical Group Co., Ltd. - Huoxiang Zhengqi Mixture
China NMPA drug inspection for Guangxi Bangqi Pharmaceutical Group Co., Ltd. published December 27, 2019. Drug: Huoxiang Zhengqi Mixture. The Xinjiang Uygur Autonomous Region Drug Administration published an announcement on December 27, 2019, detailing the r
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guangxi Bangqi Pharmaceutical Group Co., Ltd. published December 27, 2019. Drug: Huoxiang Zhengqi Mixture. The Xinjiang Uygur Autonomous Region Drug Administration published an announcement on December 27, 2019, detailing the r
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox